[1]
“THE USE OF DEXMEDETOMIDINE IN REDUCING THE SYMPTOMS OF DELIRIUM AND PSYCHOMOTOR AGITATION POST-ANESTHESIA”, REMUNOM, vol. 13, no. 09, pp. 1–22, May 2026, doi: 10.66104/vrr9wh31.